Joint Formulary & PAD

Valganciclovir - Cytomegalovirus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral solution
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Restricted antimicrobial to be used under advice of Microbiology consultant

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Valganciclovir
Indication :
Cytomegalovirus
Group Name :
Keywords :
Brand Names Include :
Valcyte
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Valganciclovir is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Cytomegalovirus.

Committee Recommendations (1)

01 Apr 13 - Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.